Trials / Completed
CompletedNCT01244607
NI-0801 in Allergic Contact Dermatitis
A Proof-of-Principle Study Investigating the Effect of Single Doses of NI-0801 on Nickel Induced Contact Dermatitis
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Light Chain Bioscience - Novimmune SA · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to assess the effect of a single dose of NI-0801 on the severity of nickel-induced allergic contact dermatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | single i.v. administration |
| DRUG | NI-0801 | single i.v. administration |
Timeline
- First posted
- 2010-11-19
- Last updated
- 2010-11-19
Source: ClinicalTrials.gov record NCT01244607. Inclusion in this directory is not an endorsement.